SparingVision Raises €44.5 Million in a round led by 4BIO Capital and UPMC Enterprises, and included Jeito Capital and Ysios Capital

by Ysios Capital

SparingVision (“the Company”), a genomic medicine company focused on ocular diseases, today announces a €44.5 million financing round. The round was led by 4BIO Capital (“4BIO”) and UPMC Ent...

Read more

Un nuevo modelo de ratón ayuda a comprender las distrofias hereditarias de retina causadas por el gen ‘CERKL’

by CIBERER - Centro de Investigación Biomédica en Red de Enfermedades Raras

Mutaciones en el gen CERKL son una causa prevalente de dos distrofias hereditarias de retina, la retinitis pigmentosa y la distrofia de conos y bastones, pero el papel funcional de este gen en la reti...

Read more

Advances in gene therapy for retinitis pigmentosa due to RPGR gene mutation

by DBGen Ocular Genomics

In the first months of 2020, positive results in gene therapy of X-linked retinitis pigmentosa (XLRP) have been reported. XLRP is an inherited genetic disorder that causes progressive vision loss, mai...

Read more

Expertos de EE UU consiguen recuperar parcialmente la visión en roedores

by Agencia Sinc

Un estudio, publicado en la revista Nature, muestra la restauración parcial de la visión en ratones ciegos mediante un método que genera químicamente nuevos fotorreceptores, encargados de captar l...

Read more

Antioxidants, key to combating retinal degeneration

by BMF Barcelona Macula Foundation: Research for Vision

Good nutrition is essential in the prevention of many pathologies and this applies to eyes too. In the case of ocular diseases such as age-related macular degeneration (AMD), cataracts, glaucoma and c...

Read more

The Barcelona Macula Foundation, committed to progress on Retinitis Pigmentosa

by BMF Barcelona Macula Foundation: Research for Vision

Once again this year the Barcelona Macula Foundation is adding its voice to World Retinitis Pigmentosa Day. As part of its commitment, the BMF is collaborating in the clinical trial the company Reneur...

Read more

The Barcelona Macula Foundation participates in World Rare Disease Day and continues researching into Stargardt’s disease and Retinitis Pigmentosa

by BMF Barcelona Macula Foundation: Research for Vision

​For another year, the Barcelona Macula Foundation (BMF) is participating in World Rare Disease Day, whose main aim is to sensitise, educate and inform the public about these pathologies and positio...

Read more

Patients with retinitis pigmentosa in pole position

by Universidad del País Vasco

Thanks to the clinical and genetic study made of all the patients with retinitis pigmentosa in Gipuzkoa by the UPV/EHU’s Department of Ophthalmology, Hospital Donostia, Biodonostia and Begisare, the...

Read more

Descubren una nueva variante genética causante de retinitis pigmentosa

by CIBERER - Centro de Investigación Biomédica en Red de Enfermedades Raras

La retinitis pigmentosa es la distrofia de retina hereditaria más común y consiste en la degeneración progresiva de los fotorreceptores, produciendo pérdida del campo visual, y disminución progre...

Read more

El CIPF participa en la identificación de un nuevo gen de retinitis pigmentosa

by Centro de Investigación Príncipe Felipe

Los sitemas de secuenciación masiva (NGS) desarrollados y aplicados en el CIPF phacen posible el análisis completo del exoma y disponer de diagnósticos precisos, fiables y económicos d...

Read more

ONCE and IDIBELL working together in a Project on Retinitis Pigmentosa

by IBEC - Institut de Bioenginyeria de Catalunya

The research deals with functional studies of genes linked to a type of inherited blindness in order to identify potential therapeutic targets

Read more

Regenerating photoreceptors by reprogramming glial cells

by Centre for Genomic Regulation

A team led by Dr Pia Cosma, ICREA research professor at the Centre for Genomic Regulation (CRG) in Barcelona, Spain, in collaboration with the Aragon Health Sciences Institute, the University of Zarag...

Read more
Subscribe to Directory
Write an Article

Recent News

Tuneable reverse photochromes in the sol...

A new technique allows the design of solid materia...

La Unidad de Chequeos de la Clínica sup...

El estudio realizado sobre una muestra significati...

Highlight

Interview with Dámaso Molero, general m...

by 3P Biopharmaceuticals

Dámaso Molero: “There are great opportunities in Latin America for ...

Not all 'good'cholesterol is healthy

by IMIM - Institut Hospital del Mar d'Investigacions Mèdiques

The work shows that people with large HDL particles have an increased ...

Photos Stream